Why the study?
Genetic variants can be used to explore the efficacy and side effects of antihypertensive medications.
Do genetic variants related to nondihydropyridine CCBs inform on the risk of diverticulosis?
Design
Other
Authors
Loading...
Genetic proxies for nondihydropyridine CCBs suggest higher diverticulosis risk; leaves open causality and needs prospective trials.
Do genetic variants related to nondihydropyridine CCBs inform on the risk of diverticulosis?
Genetic variants related to nondihydropyridine CCBs suggest a potential effect on diverticulosis risk, warranting further investigation.
Gill et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: